{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:52:01Z","timestamp":1780541521164,"version":"3.54.1"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008366","name":"Guangdong Pharmaceutical University","doi-asserted-by":"publisher","award":["242544342143"],"award-info":[{"award-number":["242544342143"]}],"id":[{"id":"10.13039\/501100008366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbrc.2026.153347","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:07:12Z","timestamp":1769270832000},"page":"153347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Crohn's disease under single-cell map: from INFLARE metaplastic cells to rare immune cell subpopulations"],"prefix":"10.1016","volume":"803","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8999-9126","authenticated-orcid":false,"given":"Qianwen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7354-6883","authenticated-orcid":false,"given":"Wenhao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3153-6396","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3978-2347","authenticated-orcid":false,"given":"Xianli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153347_bib1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.mayocp.2017.04.010","article-title":"Crohn disease: epidemiology, diagnosis, and management","volume":"92","author":"Feuerstein","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbrc.2026.153347_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.disamonth.2017.07.001","article-title":"A comprehensive review and update on Crohn's disease","volume":"64","author":"Gajendran","year":"2018","journal-title":"Dis. Mon."},{"key":"10.1016\/j.bbrc.2026.153347_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1590\/s0004-2803.201800000-73","article-title":"The onset of clinical manifestations in inflammatory bowel disease patients","volume":"55","author":"N\u00f3brega","year":"2018","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.153347_bib4","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153347_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","article-title":"Biomarkers of inflammation in inflammatory bowel disease","volume":"149","author":"Sands","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153347_bib6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.crad.2019.03.013","article-title":"Diagnostic pathways in Crohn's disease","volume":"74","author":"Rao","year":"2019","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.bbrc.2026.153347_bib7","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/diagnostics15121540","article-title":"The importance of magnetic resonance enterography in monitoring inflammatory bowel disease: a review of clinical significance and Current challenges","volume":"15","author":"Miric\u0103","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbrc.2026.153347_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4292\/wjgpt.v10.i2.35","article-title":"Crohn's disease of esophagus, stomach and duodenum","volume":"10","author":"Pimentel","year":"2019","journal-title":"World J. Gastrointest. Pharmacol. Therapeut"},{"key":"10.1016\/j.bbrc.2026.153347_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-017-2210-3","article-title":"Granulomas in the gastrointestinal tract: deciphering the Pandora's box","volume":"472","author":"Brown","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbrc.2026.153347_bib10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ueg2.12319","article-title":"Environmental risk factors for inflammatory bowel disease","volume":"10","author":"Singh","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"10.1016\/j.bbrc.2026.153347_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","article-title":"Pathophysiology of Crohn's disease inflammation and recurrence","volume":"15","author":"Petagna","year":"2020","journal-title":"Biol. Direct"},{"key":"10.1016\/j.bbrc.2026.153347_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.gastro.2016.05.050","article-title":"Commensal-Specific CD4(+) cells from patients with Crohn's Disease have a T-Helper 17 inflammatory profile","volume":"151","author":"Calder\u00f3n-G\u00f3mez","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153347_bib13","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/ijms24032696","article-title":"CD4 T-Cell subsets and the pathophysiology of inflammatory bowel disease","volume":"24","author":"Gomez-Bris","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12703\/r\/10-30","article-title":"Recent advances in understanding the Th1\/Th2 effector choice","volume":"10","author":"Butcher","year":"2021","journal-title":"Fac .Rev."},{"key":"10.1016\/j.bbrc.2026.153347_bib15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ibd\/izac199","article-title":"The pathogenicity and synergistic action of Th1 and Th17 cells in inflammatory bowel diseases","volume":"29","author":"Cao","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbrc.2026.153347_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8816041","article-title":"Th17 cells in inflammatory bowel disease: cytokines, plasticity, and therapies","volume":"2021","author":"Zhao","year":"2021","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbrc.2026.153347_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.622934","article-title":"Role of the IL23\/IL17 pathway in Crohn's Disease","volume":"12","author":"Schmitt","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/jcm13010224","article-title":"The role of IL-23 inhibitors in Crohn's Disease","volume":"13","author":"Fanizza","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.153347_bib19","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/cimb44050127","article-title":"The treatment with interleukin 17 inhibitors and immune-mediated inflammatory diseases","volume":"44","author":"\u021aiburc\u0103","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153347_bib20","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3389\/fimmu.2018.02929","article-title":"Epigenetic and transcriptional regulation in the induction, maintenance, heterogeneity, and recall-response of effector and memory Th2 cells","volume":"9","author":"Onodera","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/ijms19051447","article-title":"The initiation of Th2 immunity towards food allergens","volume":"19","author":"Ellenbogen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib22","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.20161104","article-title":"Interleukin 4 promotes the development of ex-Foxp3 Th2 cells during immunity to intestinal helminths","volume":"214","author":"Pelly","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2026.153347_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.autrev.2019.03.012","article-title":"The role of interleukin-13 in chronic inflammatory intestinal disorders","volume":"18","author":"Giuffrida","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbrc.2026.153347_bib24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","article-title":"Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis","volume":"113","author":"Fuss","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.153347_bib25","first-page":"26","article-title":"Immunological pathogenesis of inflammatory bowel disease","volume":"16","author":"Lee","year":"2018","journal-title":"Int. Res."},{"key":"10.1016\/j.bbrc.2026.153347_bib26","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.3390\/ijms21218011","article-title":"CD4 T helper cell subsets and related human immunological disorders","volume":"21","author":"Zhu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cell.2017.07.027","article-title":"Regulatory innate lymphoid cells control innate intestinal inflammation","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153347_bib28","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/febs.15238","article-title":"NKT cells and the regulation of intestinal immunity: a two-way street","volume":"287","author":"Brailey","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2026.153347_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nmeth.1315","article-title":"mRNA-Seq whole-transcriptome analysis of a single cell","volume":"6","author":"Tang","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbrc.2026.153347_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: a brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.153347_bib31","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.3390\/ijms24032943","article-title":"The evolution of single-cell RNA sequencing technology and application: progress and perspectives","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib32","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3390\/cells12151970","article-title":"A review of single-cell RNA-Seq annotation, integration, and cell-cell communication","volume":"12","author":"Cheng","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153347_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.153347_bib34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cmet.2024.03.006","article-title":"An integrated multi-omics analysis reveals osteokines involved in global regulation","volume":"36","author":"Liang","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2026.153347_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41419-023-05566-w","article-title":"Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153347_bib36","article-title":"Integration analysis of single-cell multi-omics reveals prostate cancer heterogeneity","volume":"11","author":"Bian","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bbrc.2026.153347_bib37","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jcmgh.2022.02.005","article-title":"Single-Cell analysis reveals unexpected cellular changes and transposon expression signatures in the colonic epithelium of Treatment-Na\u00efve adult Crohn's Disease patients","volume":"13","author":"Kanke","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153347_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179472","article-title":"TWIST1+FAP+ fibroblasts in the pathogenesis of intestinal fibrosis in Crohn's disease","volume":"134","author":"Zhang","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.153347_bib40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41586-024-07571-1","article-title":"Single-cell integration reveals metaplasia in inflammatory gut diseases","volume":"635","author":"Oliver","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153347_bib41","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.3748\/wjg.v27.i43.7402","article-title":"Antimicrobial peptides and the gut microbiome in inflammatory bowel disease","volume":"27","author":"Gubatan","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.153347_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126924","article-title":"Trefoil factor 3 (TFF3) is regulated by food intake, improves glucose tolerance and induces mucinous Metaplasia","volume":"10","author":"Ge","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153347_bib43","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1038\/s41467-024-51580-7","article-title":"Identification and multimodal characterization of a specialized epithelial cell type associated with Crohn's disease","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153347_bib53","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1038\/ncomms9819","article-title":"NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine","volume":"6","author":"Bai","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153347_bib56","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1038\/s41467-022-31229-z","article-title":"High-dimensional profiling reveals Tc17 cell enrichment in active Crohn's disease and identifies a potentially targetable signature","volume":"13","author":"Globig","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153347_bib57","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fimmu.2020.00896","article-title":"KLRG1 and CD103 expressions define distinct intestinal tissue-resident memory CD8 T cell subsets modulated in Crohn's Disease","volume":"11","author":"Bottois","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/j.gastro.2024.01.007","article-title":"The FOXP3(+) pro-inflammatory T cell: a potential therapeutic target in Crohn's Disease","volume":"166","author":"Kosinsky","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153347_bib64","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204269120","article-title":"Identification of a unique subset of tissue-resident memory CD4(+) T cells in Crohn's disease","volume":"120","author":"Yokoi","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.153347_bib71","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1093\/ecco-jcc\/jjab076.162","article-title":"P033 dendritic cells from patients with active IBD imprint pro-inflammatory \u03b14\u03b27+CLA+ T cells with potential for gut and skin homing","volume":"15","author":"Gordon","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbrc.2026.153347_bib72","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41467-021-22164-6","article-title":"Single-cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions","volume":"12","author":"Jaeger","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153347_bib75","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.3748\/wjg.v23.i30.5519","article-title":"Expression of Interleukin-26 is upregulated in inflammatory bowel disease","volume":"23","author":"Fujii","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.153347_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.797135","article-title":"Interleukin-26 expression in inflammatory bowel disease and its immunoregulatory effects on macrophages","volume":"9","author":"Song","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2026.153347_bib77","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4049\/jimmunol.1900318","article-title":"IL-1\u03b2 induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells","volume":"203","author":"Weiss","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib78","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1136\/gutjnl-2021-325373","article-title":"A novel unconventional T cell population enriched in Crohn's disease","volume":"71","author":"Rosati","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.153347_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gutjnl-2022-328684","article-title":"Crohn's-associated invariant T cells (CAITs) recognise small sulfonate molecules on CD1d","volume":"73","author":"Minervina","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.153347_bib82","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/ibd\/izaa316","article-title":"Crohn's Disease is associated with activation of circulating innate lymphoid cells","volume":"27","author":"Mazzurana","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbrc.2026.153347_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.656745","article-title":"Innate lymphoid cells as regulators of epithelial integrity: therapeutic implications for inflammatory bowel diseases","volume":"8","author":"Schulz-Kuhnt","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2026.153347_bib84","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302164","article-title":"Peptide derived from SLAMF1 prevents TLR4-mediated inflammation in vitro and in vivo","volume":"6","author":"Nilsen","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.bbrc.2026.153347_bib85","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-Cell analysis of Crohn's Disease lesions identifies a pathogenic cellular module associated with resistance to Anti-TNF therapy","volume":"178","author":"Martin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153347_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.gastro.2021.10.036","article-title":"Cellular plasticity, reprogramming, and regeneration: metaplasia in the stomach and beyond","volume":"162","author":"Goldenring","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153347_bib42","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3892\/mmr.2017.6730","article-title":"MicroRNA-7-5p regulates the expression of TFF3 in inflammatory bowel disease","volume":"16","author":"Guo","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2026.153347_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70170","article-title":"Ferroptosis-Related Genes are effective markers for diagnostic targets of Crohn's Disease","volume":"13","author":"Liu","year":"2025","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.bbrc.2026.153347_bib45","article-title":"Identifying hub genes in response to ustekinumab and the impact of ustekinumab treatment on fibrosis in Crohn's disease","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-022-05111-3","article-title":"LACC1 bridges NOS2 and polyamine metabolism in inflammatory macrophages","volume":"609","author":"Wei","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153347_bib47","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1136\/gutjnl-2024-334346","article-title":"DUOX2 activation drives bacterial translocation and subclinical inflammation in IBD-associated dysbiosis","volume":"74","author":"Hazime","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.153347_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738762","article-title":"New insights on CD8(+) T cells in inflammatory bowel disease and therapeutic approaches","volume":"12","author":"Casalegno Gardu\u00f1o","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8941260","article-title":"Effector, memory, and dysfunctional CD8(+) T cell fates in the Antitumor immune response","volume":"2016","author":"Reiser","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbrc.2026.153347_bib50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.20452\/pamw.614","article-title":"Biological therapy of inflammatory bowel disease","volume":"119","author":"Owczarek","year":"2009","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.bbrc.2026.153347_bib51","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.2147\/JIR.S509875","article-title":"CD8(+) T cell-derived perforin exacerbates dysbiosis and inflammatory bowel disease via \u03b2-Hydroxybutyrate suppression in Mouse colonic epithelium","volume":"18","author":"Huang","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bbrc.2026.153347_bib52","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/ijms20061283","article-title":"Killing mechanisms of Chimeric Antigen Receptor (CAR) T cells","volume":"20","author":"Benmebarek","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2016.05.001","article-title":"IL-17+ CD8+ T cells: differentiation, phenotype and role in inflammatory disease","volume":"178","author":"Srenathan","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbrc.2026.153347_bib55","article-title":"The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases","volume":"14","author":"Navarro-Comp\u00e1n","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153347_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.intimp.2013.02.004","article-title":"FoxP3, Helios, and SATB1: roles and relationships in regulatory T cells","volume":"16","author":"Grzanka","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2026.153347_bib61","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2021.08.047","article-title":"The tight junction protein ZO-1 is dispensable for barrier function but critical for effective mucosal repair","volume":"161","author":"Kuo","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153347_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/mi.2015.45","article-title":"An IL-27\/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy","volume":"9","author":"Do","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib63","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/gutjnl-2023-330856","article-title":"Protective function of sclerosing cholangitis on IBD","volume":"73","author":"Bedke","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.153347_bib65","doi-asserted-by":"crossref","first-page":"C1161","DOI":"10.1152\/ajpcell.00338.2022","article-title":"The multifunctional nature of CD103 (\u03b1E\u03b27 integrin) signaling in tissue-resident lymphocytes","volume":"323","author":"Xu","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2026.153347_bib66","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3389\/fcimb.2020.00436","article-title":"CD103 promotes the pro-inflammatory response of gastric Resident CD4(+) T cell in helicobacter pylori-positive gastritis","volume":"10","author":"Chen","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153347_bib67","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13090","article-title":"Immunobiology and conflicting roles of the human CD161 receptor in T cells","volume":"94","author":"Wyro\u017cemski","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib68","first-page":"2022","article-title":"Inhibition of inflammatory cell infiltration by antagonistic peptides that specifically bind to CCR5 via regulation of the NF-\u03baB signaling pathway in rats with colitis","volume":"20","author":"Song","year":"2024","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib69","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/all.13080","article-title":"Circulating CLA(+) T cells in atopic dermatitis and their possible role as peripheral biomarkers","volume":"72","author":"Czarnowicki","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.bbrc.2026.153347_bib70","first-page":"895","article-title":"[Targeting and role of \u03b14\u03b27 integrin in the pathophysiology of IBD and HIV infection]","volume":"31","author":"Girard","year":"2015","journal-title":"Med. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107403","article-title":"Development of dual GPBAR1 agonist and ROR\u03b3t inverse agonist for the treatment of inflammatory bowel diseases","volume":"208","author":"Biagioli","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153347_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107055","article-title":"Implications of CD39 in immune-related diseases","volume":"89","author":"Zeng","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2026.153347_bib79","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104420118","article-title":"Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d","volume":"118","author":"Almeida","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.153347_bib81","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.3390\/ijms22147618","article-title":"Innate lymphoid cells in intestinal homeostasis and inflammatory bowel disease","volume":"22","author":"Saez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib86","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3390\/ijms18112306","article-title":"The C-C chemokines CCL17 and CCL22 and their receptor CCR4 in CNS autoimmunity","volume":"18","author":"Scheu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib87","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jconrel.2024.11.070","article-title":"Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease","volume":"377","author":"Ferreira","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2026.153347_bib88","article-title":"mTOR inhibition attenuates Dextran Sulfate sodium-induced colitis by suppressing T cell proliferation and balancing TH1\/TH17\/Treg profile","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153347_bib89","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7861\/clinmed.2023-0493","article-title":"Crohn's disease: an update","volume":"23","author":"Cockburn","year":"2023","journal-title":"Clin. Med."},{"key":"10.1016\/j.bbrc.2026.153347_bib110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO Guidelines on therapeutics in Crohn's Disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbrc.2026.153347_bib111","article-title":"Budesonide for induction of remission in Crohn's disease","volume":"2015","author":"Rezaie","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2026.153347_bib112","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2020.18936","article-title":"Management of crohn disease: a review","volume":"325","author":"Cushing","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2026.153347_bib113","article-title":"Antibiotics for induction and maintenance of remission in Crohn's disease","volume":"2","author":"Townsend","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2026.153347_bib114","article-title":"Infliximab for medical induction of remission in Crohn's disease","volume":"11","author":"Gordon","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2026.153347_bib115","article-title":"Adalimumab for maintenance of remission in Crohn's disease","volume":"5","author":"Townsend","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2026.153347_bib116","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/jcm12041630","article-title":"Past, present and (Foreseeable) future of biological Anti-TNF alpha therapy","volume":"12","author":"Leone","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.153347_bib91","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1007\/s12325-023-02546-6","article-title":"Matching-Adjusted indirect comparison between Risankizumab and ustekinumab for induction and maintenance treatment of moderately to severely active Crohn's Disease","volume":"40","author":"Dubinsky","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bbrc.2026.153347_bib117","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cgh.2021.02.025","article-title":"Five-Year efficacy and safety of ustekinumab treatment in Crohn's Disease: the IM-UNITI trial","volume":"20","author":"Sandborn","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153347_bib118","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/ecco-jcc\/jjab093","article-title":"Long-Term safety and efficacy of Risankizumab treatment in patients with Crohn's Disease: results from the phase 2 open-label extension Study","volume":"15","author":"Ferrante","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbrc.2026.153347_bib119","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S2468-1253(21)00312-5","article-title":"Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis","volume":"6","author":"Singh","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153347_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13688","article-title":"Upadacitinib: mechanism of action, clinical, and translational science","volume":"17","author":"Mohamed","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bbrc.2026.153347_bib120","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.cgh.2023.03.001","article-title":"Upadacitinib is effective and safe in both ulcerative colitis and Crohn's Disease: prospective real-world experience","volume":"21","author":"Friedberg","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153347_bib121","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1053\/j.gastro.2020.01.047","article-title":"Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn's Disease","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153347_bib93","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40265-023-01840-5","article-title":"Safety of Janus kinase inhibitors in inflammatory bowel diseases","volume":"83","author":"N\u00fa\u00f1ez","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2026.153347_bib94","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00384-021-03857-2","article-title":"Surgical management of Crohn's disease: a state of the art review","volume":"36","author":"Meima-van Praag","year":"2021","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.bbrc.2026.153347_bib90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J. Med. Life"},{"key":"10.1016\/j.bbrc.2026.153347_bib95","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2192478","article-title":"Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment","volume":"15","author":"Dong","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbrc.2026.153347_bib96","first-page":"768","article-title":"Treatment strategies in inflammatory bowel diseases","volume":"120","author":"Stallmach","year":"2023","journal-title":"Dtsch Arztebl Int."},{"key":"10.1016\/j.bbrc.2026.153347_bib97","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1038\/s41598-019-45747-2","article-title":"Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: a Mendelian randomization study","volume":"9","author":"Mokry","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153347_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150018","article-title":"A Study to investigate the efficacy and safety of an Anti-Interleukin-18 monoclonal antibody in the treatment of type 2 diabetes mellitus","volume":"11","author":"McKie","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153347_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247972","article-title":"A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function","volume":"16","author":"Wlodek","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153347_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350847","article-title":"Cenicriviroc, a CCR2\/CCR5 antagonist, promotes the generation of type 1 regulatory T cells","volume":"54","author":"Madan","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbrc.2026.153347_bib101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/diagnostics12010045","article-title":"Role of B-Cell activating factor (BAFF) in inflammatory bowel disease","volume":"12","author":"Kumric","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbrc.2026.153347_bib102","article-title":"Belimumab for systemic lupus erythematosus","volume":"2","author":"Singh","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2026.153347_bib103","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/annrheumdis-2018-213032","article-title":"Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial","volume":"77","author":"Merrill","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrc.2026.153347_bib104","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.kint.2024.03.012","article-title":"A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy","volume":"105","author":"Lafayette","year":"2024","journal-title":"Kidney Int."},{"issue":"5.1.1\u20135.1.11","key":"10.1016\/j.bbrc.2026.153347_bib105","article-title":"Flow cytometry: an overview","volume":"120","author":"McKinnon","year":"2018","journal-title":"Curr. Protoc. Im."},{"key":"10.1016\/j.bbrc.2026.153347_bib106","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00262-013-1416-8","article-title":"An introduction to mass cytometry: fundamentals and applications","volume":"62","author":"Tanner","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbrc.2026.153347_bib107","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/cyto.a.23723","article-title":"Optimization of receptor occupancy assays in mass cytometry: standardization across channels with QSC beads","volume":"95","author":"Bringeland","year":"2019","journal-title":"Cytometry A"},{"key":"10.1016\/j.bbrc.2026.153347_bib108","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.molcel.2015.04.005","article-title":"The technology and biology of single-cell RNA sequencing","volume":"58","author":"Kolodziejczyk","year":"2015","journal-title":"Mol. Cell"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:41:11Z","timestamp":1773985271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":121,"alternative-id":["S0006291X26001117"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153347","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crohn's disease under single-cell map: from INFLARE metaplastic cells to rare immune cell subpopulations","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153347"}}